High Intensity Interval Training in Endometrial Cancer
Pre-operative Window Study of Interval Exercise Training as a Therapy for Endometrial Cancer
2 other identifiers
interventional
30
1 country
1
Brief Summary
This interventional trial recruits women with endometrial cancer to participate in high intensity interval training (HIIT) prior to their standard of care surgery. The study will evaluate tissue and blood to determine if HIIT training has anti-cancer effects. P
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2019
CompletedFirst Posted
Study publicly available on registry
July 18, 2019
CompletedStudy Start
First participant enrolled
September 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 8, 2024
CompletedResults Posted
Study results publicly available
August 24, 2025
CompletedOctober 15, 2025
October 1, 2025
5 years
July 16, 2019
June 25, 2025
October 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Proliferative Markers in Endometrium Before and After HIIT Exercises
Change in Ki-67 proliferation values within the HIIT intervention group between the initial biopsy and the surgical biopsy. The percentage of tumor cells that are positive for Ki-67, indicating they are in the active phases of the cell cycle (not resting). Low Ki-67 (\<10-15%): Slower-growing tumor. Intermediate (15-30%): Moderately proliferative. High (\>30%): Fast-growing, potentially more aggressive.
3 years
Study Arms (1)
HIIT exercise
EXPERIMENTALParticipants will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery
Interventions
High intensity interval training (4 to 6 sessions) prior to surgery
Eligibility Criteria
You may qualify if:
- Patients with a diagnosis of endometrial cancer who are to undergo hysterectomy and staging
- Between 40-75 years old
- Body mass index of 30-50 kg/m2
- Endometrioid histology endometrial cancer
- Presumed clinically early stage disease (disease confined to uterus only)
- Have access to a Smart Phone
- Have access to email
- Agree to visit the exercise and sport science laboratory within 2 days of SOC visit for baseline testing if enrollment procedures cannot be done on the same day.
- Agree to visit clinic 2 (+/-2wks) weeks after surgery for SOC follow-up and post surgery visit, or willing to return to exercise and sport science laboratory 2 (+/-2wks) weeks post-surgery
You may not qualify if:
- Meets American College of Sports Medicine Guidelines for physical activity (150 minutes / week)
- Currently doing HIIT
- Hospitalization for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 3 months
- Active diagnosis of psychosis or current uncontrolled substance abuse disorder
- Insulin-dependent diabetes
- Currently in another EC intervention
- Severe dementia or other memory loss condition
- Severe mental health disorder
- Severely impaired hearing or speech
- Inability to speak English
- Musculoskeletal or neuromuscular condition that limits physical activity Any condition, in the opinion of the investigators, which would prohibit safe participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Luz Andrea Cuaboy
- Organization
- UNC Lineberger Comprehensive Cancer Center
Study Officials
- PRINCIPAL INVESTIGATOR
Victoria Bae-Jump, MD
University of North Carolina, Chapel Hill
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2019
First Posted
July 18, 2019
Study Start
September 23, 2019
Primary Completion
September 8, 2024
Study Completion
September 8, 2024
Last Updated
October 15, 2025
Results First Posted
August 24, 2025
Record last verified: 2025-10